Ara
Toplam kayıt 3, listelenen: 1-3
Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker
(Cambridge Univ Press, 2017)
Objective: The product of the G72 gene is an activator of d-amino acid oxidase and has been suggested to play a role in the pathogenesis of schizophrenia. Increased G72 protein levels may be associated with disturbed ...
Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome
(Dove Medical Press Ltd, 2015)
Background: Brain-derived neurotrophic factor (BDNF) is a well-established neurotrophin that plays a role in the pathophysiology of numerous psychiatric disorders. Many studies have investigated the serum BDNF levels in ...
Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study
(Dove Medical Press Ltd, 2016)
Background: Schizophrenia is a chronic and debilitating disorder, the etiology of which remains unclear. Apoptosis is a programmed cell death mechanism that might be implicated in neuropsychiatric disorders, including ...